Apply for Review- 91 Reviewing for Other Institutions

Print Print

Before You Begin

The 91 does not typically rely on exempt determinations made by other institutions, nor does it usually allow other institutions to formally rely on 91’s exempt determinations. Reliance for exempt research may be permitted only in very limited circumstances, as determined by HSD leadership.

If your research is exempt:

Resources:

In Zipline, selecting “Mܱپ-ٱ/DZǰپ” means that one or more non-91 institutions are actively involved in conducting the research with human subjects.

This is not about where 91 researchers travel or recruit participants. It only applies when non-91 investigators or study teams are performing research activities such as obtaining consent, conducting study procedures, or collecting identifiable data.

Examples:

  • 91-only study: A 91 researcher recruits participants at Seattle Pacific University, but only 91 personnel obtain consent and conduct study activities. No SPU staff are involved in the research. This is a single-site (91-only) study.
  • Multi-site/collaborative study: 91 researchers collaborate with investigators at UCLA and Johns Hopkins. Each institution has its own study team conducting research activities under a shared protocol. This is a multi-site/collaborative study.

For more help deciding, review our Engagement Guidance or contact hsdrely@uw.edu.

91 IRB review of multi-institutional research is not guaranteed unless HSD has been consulted in advance, or the collaboration is covered by an established cooperative agreement (for example, with Fred Hutch or Seattle Children’s).

Before selecting this review path, consult HSD’s Reliance Team at hsdrely@uw.edu to determine whether 91 IRB review is appropriate for a collaborating institution.

For more information:

How the Review Process Works- 2 Phases

91 IRB review of a multi-site or collaborative study happens in 2 phases. Phase 1 must be completed and approved before Phase 2 can begin.

  • Phase 1- STUDY application: Submit a study application describing the overall protocol, any 91 specific materials, and any generic materials that will be used across sites.
  • Phase 2- SITE applications: After the STUDY application is approved, HSD creates a separate SITE application for each non 91 institution. Phase 2 includes additional researcher coordination with HSD, and each site is reviewed and approved individually. Learn more at Add Relying Sites to Approved Study.

For more information:

Steps for Submitting- Phase 1 STUDY Application

Overview

All applications must be submitted via Zipline, 91’s eIRB system. Zipline is a document management system where you upload your application form and other study documents and fill out a series of electronic SmartForms.

The order of the application steps is flexible. You may find it better to create the study record in Zipline and then complete the Word-based IRB application form, especially if you plan to be a PI proxy for a study.

91 study team members who need access to the Zipline application must complete a one-time self-registration process in Zipline before they can be added to the application. Each person must be added to the application before they are able to access it.

Individuals from non-91 institutions cannot access Zipline.

A 91 NetID is required to register. For more information:

All applications must include an IRB Protocol Form. Use the most recent version available on the HSD website or in Zipline and upload the form in Microsoft Word format. .

Two versions of the form are available:

Tips for multi-site and collaborative studies

  • Indicate in Section 1.9 that 91 IRB review is being requested on behalf of non-91 individuals or institutions.
  • Describe the overall study and research activities across all participating institutions.
  • Where possible, describe the range of procedures across sites in the STUDY application.

For more guidance, go to Preparing and Submitting the sIRB Application.

We recommend preparing all other required study documents before creating your application in Zipline. Whenever possible, upload documents in Microsoft Word format.

Required Supplements

Your application must include one or both of the following supplements, as applicable:

Planning Consent Materials for Multi-site and Collaborative Studies

For multi-institutional research, consent materials are typically developed using a study-wide template created by the overall study team, which sites then adapt to local requirements. HSD does not create this template. You may need to coordinate with investigators at other institutions to develop it.

When submitting the STUDY application in Zipline, you will need:

  • Template consent, assent, and parental permission forms (for multi-site studies where sites will create site specific versions based on a shared template)
  • 91 specific consent, assent, and parental permission forms

For more information, go to Designing the Consent Process: Considerations for Multi-institutional Research.

Other Required Documents

You may also need to prepare other required study documents and 91 site specific documents, as applicable. A full list is included in the table under Step 4.

Keep documents specific to non-91 sites for later. These materials will be submitted as part of the SITE application process.

Once your documents are ready, login to Zipline to create a new study record, complete the SmartForm application, and upload the study documents.

To create a new study record, select Create New Study from the menu:

create new study

General Tips

  • Use the help bubbles throughout Zipline for additional context if you’re unsure how to answer a question.
    Zipline help bubble icon showing contextual help
  • Navigate through the application sequentially by selecting Continue at the bottom of each page.
    Screenshot of the Continue button in Zipline
  • Jump between pages using the left‑hand navigation menu when you need to review or update specific sections.
  • Save your progress and return later by selecting Save and Edit Study if you need to complete the application in multiple sessions.
    Edit Study button under Next Steps in Zipline

SmartForm Instructions for 91 Reviewing for Other Institutions

SmartForm Page & Attachments Tips & Guidance
Basic Information SmartForm Page
Attachments:

  • IRB Protocol Form (Item 8) – Required
The Basic Information page should indicate that:

  • The study is multi‑site or collaborative (Question 4)
  • You are not requesting authorization for an external IRB to conduct the review (Question 5)
  • The 91 IRB will act as the IRB for other sites or institutions (Question 6)

The IRB Protocol must be uploaded in format.

No other documents should be uploaded in this question. An attachment is required to save the application.

Study Funding Sources SmartForm Page
Attachments:

  • Grants, contracts, and other funding information (Item 4)
For funding administered through 91:

  • Include the e‑GC1 number as the Grants Office ID (Item 3). This makes it much easier and faster for the Office of Sponsored Programs (OSP) to release funds for human subjects research.

Zipline Funding FAQs

Local Study Team Members SmartForm Page
No attachments
Can’t find someone on the list? Make sure they are registered in Zipline.

Add everyone who needs access to the application, including anyone who should be designated as a PI proxy. People must be listed on this page in order for the PI to designate them as a proxy.

Students/medical residents: Do not list your faculty advisor. Adding your faculty advisor on this page prevents them from completing faculty advisor review of your application.

Study Scope SmartForm Page
No attachments
Questions should be answered as they apply to the overall study, not just the 91 site. If you are unsure how to respond to a question, use the help text for more information.
Local Research Locations
No attachments
If your research location is not listed, select Other.

If your research consists solely of obtaining records, specimens, or other information without interacting with participants, select No direct interaction with participants.

Drugs SmartForm Page (if applicable)
Attachments:

  • Documents related to a specific study drug, such as documentation of the IND,
    Investigator’s Brochure, or Package Insert (Item 3 in the Add Drug Information window)
  • Any related documents not specific to a study drug, such as correspondence from the FDA
    or study sponsor (Item 3)
Identify all drugs to be used on human subjects as part of this study, including all investigational new drugs (INDs). An IND number is assigned by the FDA to a drug that the FDA allows to be transported across state lines for use in clinical studies prior to marketing approval.For each IND number, attach one of the following:

  • Sponsor protocol with the IND number
  • Communication from the FDA or sponsor that includes the IND number
Devices SmartForm Page (if applicable)
Attachments:

  • Documents related to a specific study device, such as documentation of the IDE or HDE, the Package Insert, or other device‑specific communication (Item 3 in the Add Device window)
  • Any related documents not specific to a study device, such as correspondence from the FDA or study sponsor (Item 3)
Identify all devices to be evaluated for safety and effectiveness or used as an HUD on human subjects. Include all information the IRB needs to identify and evaluate any device with exemptions or claimed exemptions. Also, attach information from the study sponsor or the FDA verifying the exemption status of each exempt device.
Study Related Documents Page
Attachments:

  • Generic Templates for Consent Forms, Assent Forms, and Parental Permission Forms that will be supplied to other sites for adaptation or use
  • Generic Templates for Recruitment Materials
  • Other documents that apply to the study as a whole and not just the 91 site, such as the study protocol, data collection forms, and any required supplements
    • SUPPLEMENT Multi-site or Collaborative Research
    • SUPPLEMENT Diversity Plan for Clinical Trials (if applicable)
Only attach documents that apply to the overall study and are not specific to the 91 site, such as generic study consent templates that will be adapted for each site. Documents specific to the 91 site should be attached on the Local Site Documents Page.
Local Site Documents Page
Attachments:

  • 91 Specific Consent Forms, Assent Forms, and Parental Permission Forms (Item 1)
  • 91 Specific Recruitment materials (Item 2)
  • PI’s Curriculum Vitae or biosketch (Item 3)
  • IRB 101 Training Certificate- Required for student and medical resident principal investigators (Item 3)
  • Other documents specific to the site that have not already been provided (Item 3)
Consent forms:

  • Consent materials must be uploaded to Item 1 to be watermarked

Recruitment materials:

  • HSD encourages uploading descriptions of recruitment and screening materials instead of the materials themselves to allow flexibility for minor changes without submitting a modification for IRB approval.

Other documents:

  • Student and medical resident PIs must attach their IRB 101 training certificate in Item 3.
  • Any data collection forms, study instruments, surveys, and application supplements specific to 91 should be attached in Item 3.

The Manage Ancillary Review activity is used to obtain and document faculty advisor review when a student or medical resident is the principal investigator (PI) for the IRB application. Do not add the faculty advisor to the study team on the Zipline application before the faculty advisor has submitted the faculty advisor review. The system will not allow a member of the study team to submit an ancillary review for the study.

The faculty advisor review may occur concurrently with HSD or IRB review of an application. However, final IRB approval will not be issued until the required faculty advisor review is completed.

Your faculty advisor will receive an email notification when the application is submitted to HSD. For more information:

screenshot of the Manage Ancillary Reviews activity

Checking the application for errors and omissions helps you to include all the relevant information, which is essential for receiving a timely review of your study. Automatic system error checking identifies any omitted answers to questions that are required for every application. A red asterisk (*) indicates required questions.

HSD also recommends looking over the forms to see what you may have missed, especially:

  • Questions that are relevant to your study but are not required for all studies (no asterisks)
  • Documents that should be attached

The Submit activity must be completed once the application is ready to go to HSD. This activity:

  • Must be completed by the PI or the PI Proxy
  • Changes the application state from Pre-Submission to Pre-Review
  • Sends the item to HSD for review
  • Removes the study team’s ability to make edits while the study is in review unless HSD requests more information or a change to the study

Screenshot of the submit button

What to Expect After Submitting

An HSD staff member will be assigned to your application as the IRB coordinator. The PI, any PI proxies, and the primary contact will receive email notifications:

  • If HSD staff need additional information or changes to complete the review
  • To inform you about the outcome of the review, including a formal determination letter with more information

You can check the application status in the study workspace in Zipline at any time.

Screenshot of the review diagram with Pre-Review highlighted

 

Once the STUDY is approved, HSD will work with you to begin adding relying SITES and site specific information, including documents such as consent materials.

For more information: